<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: To investigate the expression of p53 protein in malignant and benign lymphoid tissues </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Tissue from 42 non-Hodgkin's <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, 10 Hodgkin's <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, three <z:mpath ids='MPATH_483'>atypical hyperplasias</z:mpath> and five benign reactive <z:mpath ids='MPATH_134'>hyperplasias</z:mpath> was studied immunohistochemically for the expression of p53 protein </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: Of the 42 non-Hodgkin's <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, 13 (31%) were positive for p53 in some of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> cells </plain></SENT>
<SENT sid="3" pm="."><plain>In two cases the proportion of positive cells was more than 10% and in four cases it was between 1-5% </plain></SENT>
<SENT sid="4" pm="."><plain>These six cases consisted of three Burkitt's <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, one <z:e sem="disease" ids="C1521815" disease_type="Neoplastic Process" abbrv="">immunoblastic</z:e> <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, one <z:e sem="disease" ids="C1516391" disease_type="Neoplastic Process" abbrv="">centroblastic</z:e> diffuse <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and one angioimmunoblastic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>In seven cases the proportion of p53 positive <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> cells was less than 1% </plain></SENT>
<SENT sid="6" pm="."><plain>These cases comprised three <z:e sem="disease" ids="C1516391" disease_type="Neoplastic Process" abbrv="">centroblastic</z:e> diffuse, three <z:e sem="disease" ids="C1516391" disease_type="Neoplastic Process" abbrv="">centroblastic</z:e> polymorphic diffuse, and one angioimmunoblastic type <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>In three out of 10 (30%) Hodgkin's <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, a proportion of the Reed-Sternberg cells were p53 positive </plain></SENT>
<SENT sid="8" pm="."><plain>One of these was a mixed cellular subtype and two nodular sclerosing subtypes </plain></SENT>
<SENT sid="9" pm="."><plain>p53 protein was not expressed in the three <z:mpath ids='MPATH_483'>atypical hyperplasias</z:mpath> or the five benign reactive <z:mpath ids='MPATH_134'>hyperplasias</z:mpath> of the lymph nodes </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: The presence of p53 positivity in non-Hodgkin's and Hodgkin's <z:hpo ids='HP_0002665'>lymphomas</z:hpo> indicates that mutations of the p53 gene may play a part in the development of these <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>The concentration of p53 positivity in high grade <z:hpo ids='HP_0002665'>lymphomas</z:hpo> suggests that p53 is involved in the transformation of low grade <z:hpo ids='HP_0002665'>lymphomas</z:hpo> to more aggressive types </plain></SENT>
<SENT sid="12" pm="."><plain>Because no p53 positivity was observed in benign lesions of the lymph nodes, positive p53 immunohistochemical staining in a lymphoid lesion suggests <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> </plain></SENT>
</text></document>